Intelligence / Healthtech / New Clinical Trials / Hamad Medical Corporation
Hamad Medical Corporation
28 Oct 2026: Trial registered · Middle East Study of Infections in Patients With Hematological Malignancies. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 28 Oct 2026
- Title
- Middle East Study of Infections in Patients With Hematological Malignancies
- Conditions
- Hematological Malignancy, Hematopoetic Stem Cell Transplantation, Bloodstream Infection
- Study Type
- Observational
- Status
- Recruiting
- Countries
- Jordan, Oman, Qatar, Saudi Arabia, United Arab Emirates
- Country
- Jordan
- Reference
- NCT07900542
- Location
- Jordan, Oman, Qatar
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Find the decision makers at Hamad Medical Corporation
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Across AOS Research
Other records for Hamad Medical Corporation in our registers.
More from Jordan
New Clinical Trials
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.